Skip to main content
Selvita S.A. logo

Selvita S.A. — Investor Relations & Filings

Ticker · SLV ISIN · PLSLVCR00029 LEI · 25940057WQ9YP5MOQF28 WAR Professional, scientific and technical activities
Filings indexed 1,179 across all filing types
Latest filing 2025-11-25 Director's Dealing
Country PL Poland
Listing WAR SLV

About Selvita S.A.

https://selvita.com/

Selvita S.A. is a preclinical contract research organization (CRO) providing integrated services for the pharmaceutical and biotechnology sectors. The company offers comprehensive solutions across the drug discovery and development continuum, from target validation to preclinical candidate nomination. Core drug discovery capabilities include medicinal chemistry, pharmacology, DMPK, and protein sciences, supporting a wide range of modalities such as small molecules, antibodies, and protein degraders. For drug development, Selvita provides analytical support for small and large molecules, formulation, microbiology services, and manufacturing for clinical trials. The company operates under GMP and GLP quality standards, offering flexible engagement models that range from standalone studies to fully integrated programs.

Recent filings

Filing Released Lang Actions
Powiadomienie 1
Director's Dealing Classification · 100% confidence The document is a formal notification of a transaction by a person discharging managerial responsibilities (PDMR) or a person closely associated with them, as required by Article 19 of the Market Abuse Regulation (MAR). It details share transactions (specifically receiving a donation of shares) by an entity associated with a member of the Supervisory Board of Selvita S.A. This falls under the category of Director's Dealing (DIRS).
2025-11-25 Polish
Zawiadomienia od osoby pełniącej obowiązki zarządcze w Spółce / Notifications from person discharging managerial responsibilities in the Company - Content (PL)
Director's Dealing Classification · 100% confidence The document is a notification regarding a change in share ownership by a member of the Supervisory Board (Paweł Przewięźlikowski) and a related entity (Benevora Fundacja Rodzinna). It specifically references 'art. 19 ust. 1 Rozporządzenia MAR', which is the standard regulatory requirement for reporting transactions by persons discharging managerial responsibilities (PDMRs) and their closely associated persons. This falls under the category of Director's Dealing.
2025-11-25 Polish
Otrzymanie istotnego zlecenia / Receipt of a significant purchase order - Content (PL)
Regulatory Filings Classification · 100% confidence The document is a formal announcement from Selvita S.A. regarding a new service contract (Zlecenie) with a US-based biotechnology client. It details the contract value, duration, and scope of work. Since this is a specific corporate announcement regarding a business contract that does not fit into categories like M&A, dividends, or financial reports, it falls under the general regulatory announcement category.
2025-11-21 Polish
19.1.MAR
Director's Dealing Classification · 100% confidence The document is a formal notification of a transaction by a person discharging managerial responsibilities (PDMR) or a person closely associated with them, as required by Article 19 of the Market Abuse Regulation (MAR). It details the name of the person, the issuer (Selvita S.A.), the nature of the transaction (receipt of a donation of shares), and the volume/price. This falls under the category of Director's Dealing (DIRS), which covers insider transactions and related party disclosures.
2025-11-21 Polish
19.1.MAR
Director's Dealing Classification · 100% confidence The document is a formal notification of a transaction by a person discharging managerial responsibilities (PDMR), specifically the CEO (Prezes Zarządu) of Selvita S.A. It explicitly references Article 19(1) of the Market Abuse Regulation (MAR). This type of disclosure, involving share transactions by company insiders, is classified as a Director's Dealing (DIRS).
2025-11-21 Polish
Zawiadomienia od osoby pełniącej obowiązki zarządcze w Spółce / Notifications from person discharging managerial responsibilities in the Company - Content (PL)
Director's Dealing Classification · 100% confidence The document is a notification regarding share transactions by a company director (Bogusław Sieczkowski) and a closely related entity (CapitalS Fundacja Rodzinna). It explicitly references Article 19 of the MAR (Market Abuse Regulation), which is the standard regulatory framework for reporting insider dealings. Since it details the transfer of shares by a director, it falls under the category of Director's Dealing.
2025-11-21 Polish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.